表紙
市場調查報告書
商品編碼
909470

VNA (廠商中性檔案) 及PACS (醫療用影像管理系統)的全球市場

VNA & PACS

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 178 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球VNA (廠商中性檔案) 及PACS (醫療用影像管理系統)的市場調查,市場定義和概要,市場趨勢·市場成長的各種影響因素分析,競爭企業與市場佔有率,世界及各地區·各主要國家的市場規模的變化與預測,各種區分的明細,主要企業簡介等資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球企業佔有率
    • 企業佔有率方案:實際成果·預測
  • 主要企業
  • 市場趨勢·成長推進因素
  • 全球市場的展望:市場規模·市場佔有率的轉變·預測
    • 各產品
    • PACS
    • VNA軟體
    • 各最終用途
    • 醫院
    • 診斷影像中心
    • 其他

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 其他
  • 亞太地區
  • 其他地區

第4章 競爭企業

  • AGFA HEALTHCARE NV
  • DELL TECHNOLOGIES
  • FUJIFILM Holdings
  • IBM CORPORATION
  • KONINKLIJKE PHILIPS NV
  • LEXMARK INTERNATIONAL
  • MCKESSON CORPORATION
  • NOVARAD
  • SIEMENS AG

第5章 調查資料

目錄
Product Code: MCP15534

Abstract:

Global Vendor Neutral Archive (VNA) and PACS Market to Reach $4.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Vendor Neutral Archive (VNA) and PACS estimated at US$3 Billion in the year 2020, is projected to reach a revised size of US$4.1 Billion by 2027, growing at aCAGR of 4.4% over the period 2020-2027. PACS, one of the segments analyzed in the report, is projected to record 4.2% CAGR and reach US$2.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the VNA Software segment is readjusted to a revised 5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $886.5 Million, While China is Forecast to Grow at 4.2% CAGR

The Vendor Neutral Archive (VNA) and PACS market in the U.S. is estimated at US$886.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$724 Million by the year 2027 trailing a CAGR of 4.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 3.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Select Competitors (Total 46 Featured) -

  • Agfa Healthcare NV
  • Dell Technologies
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • IBM Corporation
  • Koninklijke Philips NV
  • Lexmark International, Inc.
  • McKesson Corporation
  • Novarad
  • Siemens AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for VNA & PACS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for VNA & PACS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for VNA & PACS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for PACS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for PACS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for PACS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for VNA Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for VNA Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for VNA Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Diagnostic Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 19: USA Current & Future Analysis for VNA & PACS by Product - PACS and VNA Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 20: USA Historic Review for VNA & PACS by Product - PACS and VNA Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: USA 15-Year Perspective for VNA & PACS by Product - Percentage Breakdown of Value Sales for PACS and VNA Software for the Years 2012, 2020 & 2027
    • TABLE 22: USA Current & Future Analysis for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 23: USA Historic Review for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: USA 15-Year Perspective for VNA & PACS by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 25: Canada Current & Future Analysis for VNA & PACS by Product - PACS and VNA Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: Canada Historic Review for VNA & PACS by Product - PACS and VNA Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: Canada 15-Year Perspective for VNA & PACS by Product - Percentage Breakdown of Value Sales for PACS and VNA Software for the Years 2012, 2020 & 2027
    • TABLE 28: Canada Current & Future Analysis for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: Canada Historic Review for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: Canada 15-Year Perspective for VNA & PACS by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 31: Japan Current & Future Analysis for VNA & PACS by Product - PACS and VNA Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Japan Historic Review for VNA & PACS by Product - PACS and VNA Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: Japan 15-Year Perspective for VNA & PACS by Product - Percentage Breakdown of Value Sales for PACS and VNA Software for the Years 2012, 2020 & 2027
    • TABLE 34: Japan Current & Future Analysis for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Japan Historic Review for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Japan 15-Year Perspective for VNA & PACS by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 37: China Current & Future Analysis for VNA & PACS by Product - PACS and VNA Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: China Historic Review for VNA & PACS by Product - PACS and VNA Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: China 15-Year Perspective for VNA & PACS by Product - Percentage Breakdown of Value Sales for PACS and VNA Software for the Years 2012, 2020 & 2027
    • TABLE 40: China Current & Future Analysis for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: China Historic Review for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: China 15-Year Perspective for VNA & PACS by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 43: Europe Current & Future Analysis for VNA & PACS by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 44: Europe Historic Review for VNA & PACS by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: Europe 15-Year Perspective for VNA & PACS by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 46: Europe Current & Future Analysis for VNA & PACS by Product - PACS and VNA Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Europe Historic Review for VNA & PACS by Product - PACS and VNA Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: Europe 15-Year Perspective for VNA & PACS by Product - Percentage Breakdown of Value Sales for PACS and VNA Software for the Years 2012, 2020 & 2027
    • TABLE 49: Europe Current & Future Analysis for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe Historic Review for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: Europe 15-Year Perspective for VNA & PACS by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 52: France Current & Future Analysis for VNA & PACS by Product - PACS and VNA Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 53: France Historic Review for VNA & PACS by Product - PACS and VNA Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: France 15-Year Perspective for VNA & PACS by Product - Percentage Breakdown of Value Sales for PACS and VNA Software for the Years 2012, 2020 & 2027
    • TABLE 55: France Current & Future Analysis for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: France Historic Review for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: France 15-Year Perspective for VNA & PACS by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 58: Germany Current & Future Analysis for VNA & PACS by Product - PACS and VNA Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Germany Historic Review for VNA & PACS by Product - PACS and VNA Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: Germany 15-Year Perspective for VNA & PACS by Product - Percentage Breakdown of Value Sales for PACS and VNA Software for the Years 2012, 2020 & 2027
    • TABLE 61: Germany Current & Future Analysis for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Germany Historic Review for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: Germany 15-Year Perspective for VNA & PACS by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 64: Italy Current & Future Analysis for VNA & PACS by Product - PACS and VNA Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Italy Historic Review for VNA & PACS by Product - PACS and VNA Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: Italy 15-Year Perspective for VNA & PACS by Product - Percentage Breakdown of Value Sales for PACS and VNA Software for the Years 2012, 2020 & 2027
    • TABLE 67: Italy Current & Future Analysis for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Italy Historic Review for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Italy 15-Year Perspective for VNA & PACS by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 70: UK Current & Future Analysis for VNA & PACS by Product - PACS and VNA Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: UK Historic Review for VNA & PACS by Product - PACS and VNA Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: UK 15-Year Perspective for VNA & PACS by Product - Percentage Breakdown of Value Sales for PACS and VNA Software for the Years 2012, 2020 & 2027
    • TABLE 73: UK Current & Future Analysis for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: UK Historic Review for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: UK 15-Year Perspective for VNA & PACS by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Current & Future Analysis for VNA & PACS by Product - PACS and VNA Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Rest of Europe Historic Review for VNA & PACS by Product - PACS and VNA Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: Rest of Europe 15-Year Perspective for VNA & PACS by Product - Percentage Breakdown of Value Sales for PACS and VNA Software for the Years 2012, 2020 & 2027
    • TABLE 79: Rest of Europe Current & Future Analysis for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Rest of Europe Historic Review for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: Rest of Europe 15-Year Perspective for VNA & PACS by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 82: Asia-Pacific Current & Future Analysis for VNA & PACS by Product - PACS and VNA Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Asia-Pacific Historic Review for VNA & PACS by Product - PACS and VNA Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: Asia-Pacific 15-Year Perspective for VNA & PACS by Product - Percentage Breakdown of Value Sales for PACS and VNA Software for the Years 2012, 2020 & 2027
    • TABLE 85: Asia-Pacific Current & Future Analysis for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Asia-Pacific Historic Review for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Asia-Pacific 15-Year Perspective for VNA & PACS by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 88: Rest of World Current & Future Analysis for VNA & PACS by Product - PACS and VNA Software - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Rest of World Historic Review for VNA & PACS by Product - PACS and VNA Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Rest of World 15-Year Perspective for VNA & PACS by Product - Percentage Breakdown of Value Sales for PACS and VNA Software for the Years 2012, 2020 & 2027
    • TABLE 91: Rest of World Current & Future Analysis for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Rest of World Historic Review for VNA & PACS by End-Use - Hospitals, Diagnostic Imaging Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Rest of World 15-Year Perspective for VNA & PACS by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Imaging Centers and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 46